Sigma Planning Corp Sells 5,312 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Sigma Planning Corp trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 51.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,958 shares of the exchange traded fund’s stock after selling 5,312 shares during the quarter. Sigma Planning Corp’s holdings in SPDR S&P Biotech ETF were worth $443,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. James J. Burns & Company LLC raised its position in SPDR S&P Biotech ETF by 5.0% in the 3rd quarter. James J. Burns & Company LLC now owns 3,062 shares of the exchange traded fund’s stock valued at $224,000 after buying an additional 146 shares during the last quarter. Moser Wealth Advisors LLC grew its stake in shares of SPDR S&P Biotech ETF by 10.4% during the 3rd quarter. Moser Wealth Advisors LLC now owns 2,041 shares of the exchange traded fund’s stock worth $149,000 after acquiring an additional 193 shares in the last quarter. Viewpoint Capital Management LLC grew its stake in shares of SPDR S&P Biotech ETF by 25.0% during the 3rd quarter. Viewpoint Capital Management LLC now owns 1,000 shares of the exchange traded fund’s stock worth $73,000 after acquiring an additional 200 shares in the last quarter. HB Wealth Management LLC grew its stake in shares of SPDR S&P Biotech ETF by 4.9% during the 4th quarter. HB Wealth Management LLC now owns 4,280 shares of the exchange traded fund’s stock worth $382,000 after acquiring an additional 200 shares in the last quarter. Finally, Global Retirement Partners LLC grew its stake in shares of SPDR S&P Biotech ETF by 9.1% during the 4th quarter. Global Retirement Partners LLC now owns 2,474 shares of the exchange traded fund’s stock worth $220,000 after acquiring an additional 206 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 2.0 %

Shares of XBI opened at $82.22 on Friday. The stock has a market capitalization of $6.39 billion, a P/E ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The company has a 50 day moving average of $92.88 and a 200-day moving average of $84.55.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.